The extracellular matrix (ECM) in primary breast cancers is significantly altered compared with normal breast tissue and may provide new biomarkers for cancer diagnosis,1 2. 3. – 4 metastasis prediction,5,6 and prognosis of survival.7 Cancer metastasis is a multistep process in which the tumor microenvironment (TME) facilitates cancer cell–ECM interactions that are necessary for metastasis to occur.8 The ECM in breast tumors is composed of a complex meshwork of fibrillar collagens, glycoproteins, and proteoglycans,9 which profoundly affect metastasis, as well as proliferation, angiogenesis, adhesion, migration, invasion, macromolecular transport, and drug delivery.9 10. 11. 12. – 13 Multiple molecular mechanisms, such as ECM degradation by proteases secreted by cancer cells and dysregulated ECM synthesis by tumor-associated stromal cells, have been implicated in the formation of the significantly altered ECM of breast tumors8 that include structural changes in the fiber patterns of fiber-forming ECM components. Collagen I (Col1) fibers are the major structural ECM component in breast tumors,5,6,9,14,15 and increased stromal Col1 has been found to facilitate breast tumor formation, invasion, and metastasis.5,6